Alvesco in 2026: What's the Real Availability Picture?

If you depend on Alvesco (Ciclesonide) to manage your asthma, you've probably noticed that finding it at your pharmacy isn't always easy. Patients across the country have reported difficulty locating Alvesco — and the frustration is real.

So is Alvesco officially in shortage? What's driving the availability problems? And what can you do about it? Here's the latest update for 2026.

Is Alvesco Still in Shortage?

As of early 2026, Alvesco is not officially listed on the FDA Drug Shortage Database. That means the FDA doesn't classify it as being in a formal shortage.

However, that doesn't tell the whole story. Many patients report persistent difficulty finding Alvesco at local pharmacies. The disconnect between the FDA's classification and real-world experience comes down to how shortages are defined. The FDA tracks shortages when manufacturers report supply disruptions — but Alvesco's availability issues are more about distribution patterns and pharmacy stocking decisions than manufacturing problems.

For a deeper dive into why this happens, read our explainer on why Alvesco is so hard to find.

Why Is Alvesco Hard to Find?

Several factors contribute to Alvesco's availability challenges:

• Brand-only with no generic: No generic Ciclesonide inhaler exists in the U.S. The earliest a generic could arrive is 2028. This means Covis Pharma is the sole supplier.
• Single manufacturer: Covis Pharma acquired Alvesco from AstraZeneca in 2018. As a smaller company, their distribution footprint is narrower than major pharma manufacturers.
• Low stocking priority: Pharmacies stock based on demand. With more popular alternatives available (Fluticasone, Budesonide), many pharmacies don't carry Alvesco routinely.
• Insurance barriers: Prior authorization requirements and step therapy mandates slow down access, creating the perception that the drug is unavailable when it's really an access issue.

How Much Does Alvesco Cost in 2026?

Cost remains a significant factor in Alvesco access. Here's what you can expect:

• Cash price (no insurance): $275-$411 per inhaler (6.1 gm canister, 60 inhalations)
• With discount card (SingleCare, GoodRx): As low as $270 per inhaler
• With Alvesco Savings Card (commercially insured): As low as $0 per prescription (max savings $525)
• Covis Transition Program (cash pay with home delivery): $60 per prescription
• Insurance copay (if covered): Typically $15-$75, but Alvesco is often placed in higher tiers

For all the details on reducing your cost, see our complete guide on how to save money on Alvesco.

Are There New Options in 2026?

While no generic Ciclesonide inhaler has launched yet, the ICS market continues to evolve:

• Generic Fluticasone Propionate HFA has become the go-to affordable alternative since Flovent was discontinued in 2024
• Combination inhalers (ICS + long-acting bronchodilator) may be appropriate if your asthma isn't well-controlled on an ICS alone
• Biosimilar and authorized generic inhalers continue to enter the market, expanding choices and driving down costs

See our full comparison of alternatives to Alvesco.

How to Find Alvesco in Stock

If you need to fill your Alvesco prescription, here are actionable steps:

1. Use Medfinder to check which pharmacies near you have Alvesco in stock right now
2. Try independent pharmacies — they often have more flexible ordering and may stock niche medications
3. Ask your pharmacy to order it — most can get it within 1-3 business days if the distributor has stock
4. Consider the Covis Transition Pharmacy Program — $60 per fill with home delivery, bypassing local stock issues
5. Plan ahead — request refills when you're 75% through your current inhaler, not when it's empty

For more detailed strategies, read our guide on how to find Alvesco in stock near you.

Final Thoughts

Alvesco isn't in an official FDA-recognized shortage, but real-world availability continues to be a challenge for many patients in 2026. The combination of brand-only status, a single manufacturer, and limited pharmacy stocking means you'll likely need to be proactive about sourcing your inhaler.

Stay ahead of the problem: use Medfinder to check stock, take advantage of the manufacturer savings programs, and keep an open conversation with your doctor about backup plans. If Alvesco becomes consistently unavailable, there are effective alternatives worth discussing.